Evidence Lacking for Prenatal Vitamin D Supplementation

Share this content:
Evidence Lacking for Prenatal Vitamin D Supplementation
Evidence Lacking for Prenatal Vitamin D Supplementation

THURSDAY, Nov. 30, 2017 (HealthDay News) -- Prenatal vitamin D supplementation during pregnancy may have some benefits, although the evidence is low quality, according to research published online Nov. 29 in The BMJ.

Daniel E. Roth, M.D., Ph.D., from the University of Toronto, and colleagues conducted a systematic review and meta-analysis of trials to estimate the effects of vitamin D supplementation during pregnancy on 11 maternal and 27 neonatal/infant outcomes. Data from 43 trials with 8,406 participants were eligible for meta-analyses.

The researchers found that vitamin D increased maternal/cord serum concentration of 25-hydroxyvitamin D, with a weak dose-response effect. Maternal clinical outcomes were rarely determined or reported, and no evidence of benefits was seen with available data. The mean birth weight was increased with vitamin D, and there was a reduction in the risk for small-for-gestational-age births (risk ratio, 0.60; 95 percent confidence interval, 0.40 to 0.90), but in sensitivity and subgroup analyses the findings were not robust. Vitamin D supplementation had no impact on preterm birth (risk ratio, 1.0; 95 percent confidence interval, 0.77 to 1.30). Strong evidence was found for prenatal vitamin D reducing the risk of wheeze in offspring by age 3 years (risk ratio, 0.81; 95 percent confidence interval, 0.67 to 0.98). An overall low risk of bias was seen in eight of 43 trials.

"The evidence to date seems insufficient to guide clinical or policy recommendations," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »